ASCO 2022 Conference Coverage

 

MDS and MPN
08:09

ASCO 2022 Conference Coverage

ASCO 2022 on the Characteristics of Patients With Myelofibrosis on Ruxolitinib for Three or More Years

FEATURING Lucia Masarova
  • 152 views
  • June 21, 2022
01:44

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Characteristics of Patients With Myelofibrosis on Ruxolitinib for Three or More Years

FEATURING Lucia Masarova
  • 13 views
  • June 21, 2022
14:33

ASCO 2022 Conference Coverage

ASCO 2022 Navitoclax + Ruxolitinib in JAKi-Naive Pts With MF: Preliminary Safety & Efficacy in a Multicenter, Open-Label Phase 2 Study

FEATURING Francesco Passamonti
  • 116 views
  • June 17, 2022
  • 1
58

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Navitoclax + Ruxolitinib in JAKi-Naive Pts With MF: Preliminary Safety & Efficacy in a Multicenter, Open-Label Phase 2 Study

FEATURING Francesco Passamonti
  • 16 views
  • June 17, 2022